TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03952975

Intervention type: OTHER
Group type: OTHER
Intervention: Vaginal bleeding
Description: Vaginal bleeding was classified into four categories according to the timing. Intraoperative bleeding (defined as bleeding that occur during the LEEP procedure), early postoperative bleeding (defined as bleeding that occur between end of the LEEP procedure and home discard), late postoperative bleeding (defined as bleeding that occur within two weeks after the home discard, and required hemostatic interventions such as electrocauterization, gauze packing, or cervical suturing, excluding menstrual bleeding), and persistent postoperative bleeding (defined as vaginal bleeding that occurs more than 2 weeks after the procedure with or without required hemostatic interventions, excluding menstrual bleeding).

Intervention type: OTHER
Group type: OTHER
Intervention: Vaginal bleeding
Description: Vaginal bleeding was classified into four categories according to the timing. Intraoperative bleeding (defined as bleeding that occur during the LEEP procedure), early postoperative bleeding (defined as bleeding that occur between end of the LEEP procedure and home discard), late postoperative bleeding (defined as bleeding that occur within two weeks after the home discard, and required hemostatic interventions such as electrocauterization, gauze packing, or cervical suturing, excluding menstrual bleeding), and persistent postoperative bleeding (defined as vaginal bleeding that occurs more than 2 weeks after the procedure with or without required hemostatic interventions, excluding menstrual bleeding).
Study: NCT01442103

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Normlgel Ag
Description: Normlgel Ag dressing will be changed together with planned investigation visits. Dressing changes between visits will be performed at home on Day 3 or 4 of each week by subject or caregiver and documented in a dressing log.
Study: NCT04279626

Intervention type: PROCEDURE
Intervention: LETS-M
Description: A 1.5-centimeter skin incision was made over the umbilicus, and the abdominal wall was opened layer by layer with an open method. A wound retractor (Alexis, 2-4 centimeter; Applied Medical Resources Corp., Rancho Santa Margarita, CA) was placed, and the glove port was set up, with a 10-millimeter trocar in the thumb over patient's right side, and a 5-millimeter trocar in the little finger over the left side. The pneumoperitoneum was established. A 10-millimeter rigid laparoscope was inserted via the 10-millimeter trocar and controlled by the assistant. The ancillary 5-millimeter port was made over the left lower abdomen under laparoscope inspection. The surgeon performed the surgery via the two 5-millimeter trocars.
Study: NCT02804152

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: CBT for Chronic Pain in Pregnancy
Description: The content will be included in 8 weekly sessions, i.e., sessions 1-3 (Education on chronic pain, Theories of pain and diaphragmatic breathing and Progressive muscle relaxation and visual imagery), sessions 4 and 5 (Automatic thoughts and pain and Cognitive restructuring), sessions 7, 8 and 10 (Pleasant activity scheduling, Time-based pacing and Sleep hygiene), sessions 6 and 9 (Stress management and Anger management). Following this content, 1-2 sessions will be dedicated to review and reinforcement of key concepts or addressing any stuck points as well as cover content in session 11 (Relapse Prevention). The last session of therapy would include a review of achievements and commitment to continued application of CBT for chronic pain in participants daily lives.
Study: NCT03748004

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: IPS/SP
Description: The 72 recruited clients receiving primary care services from one DTES clinical site who are employment ready will be randomly assigned to IPS and Peer Support (experimental group) or WorkBC control group

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: WorkBC
Description: 36 out of the 72 participants who live in the DTES will be randomly assigned to the control group (WorkBC). Participants will be provided with WorkBC employment services.
Study: NCT03290599

Intervention type: OTHER
Intervention: Mini Mental and Modified Mini Mental Test
Description: Mini Mental Test was used for literate patients and Modified mini mental test was used for illiterated patients

Intervention type: OTHER
Intervention: Mini Mental and Modified Mini Mental Test
Description: Mini Mental Test was used for literate patients and Modified mini mental test was used for illiterated patients
Study: NCT02554461

Intervention type: OTHER
Intervention: advise for exercices given by team staff
Description: To respond to questions asked:~it is not the investigator who decides on the intervention, but the daily team staff (e.g. trainer, coach, PT,.....). So no predetermined intervention is provided

Intervention type: OTHER
Intervention: advise for exercices given by team staff
Description: To respond to questions asked:~it is not the investigator who decides on the intervention, but the daily team staff (e.g. trainer, coach, PT,.....). So no predetermined intervention is provided
Study: NCT01685515

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Decitabine and Tetrahydrouridine
Description: Oral Decitabine and Oral Tetrahydrouridine (THU) given 1-2 hours apart on 2 consecutive days over 8 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Plain water will be dispensed at a similar volume and in the same containers as study drug. The water placebo has a similar appearance and taste to the study drug, since the study drug is highly diluted in water.
Study: NCT00554632

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ethinyl estradiol and norgestimate
Description: Oral contraceptive

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ethinyl estradiol and norelgestromin
Description: Transdermal hormonal contraceptive changed weekly
Study: NCT04328077

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TERN-101
Description: Investigational drug

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TERN-101
Description: Investigational drug

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TERN-101
Description: Investigational drug

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo
Study: NCT02983201

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: filiform needle
Description: Patients will receive filiform needle treatment only.During the study period, a maximum of two courses of acupuncture therapy, consisting of 7 sessions each, will be administered. Treatment will be given twice per week. After completing the first course of 7 sessions, there will be a break of one week, at the end of which the second course will commence. Treatment will come to a halt as soon as the pain has totally subsided.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: filiform needle
Description: Patients will receive filiform needle treatment only.During the study period, a maximum of two courses of acupuncture therapy, consisting of 7 sessions each, will be administered. Treatment will be given twice per week. After completing the first course of 7 sessions, there will be a break of one week, at the end of which the second course will commence. Treatment will come to a halt as soon as the pain has totally subsided.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: thumbtack needle
Description: Thumbtack intra-dermal needle will be applied to selected acupuncture points after filiform needle treatment. The thumbtack needle will remain embedded in the patient's dermal part for 2-3 days as per instruction.During the study period, a maximum of two courses of acupuncture therapy, consisting of 7 sessions each, will be administered. Treatment will be given twice per week. After completing the first course of 7 sessions, there will be a break of one week, at the end of which the second course will commence. Treatment will come to a halt as soon as the pain has totally subsided.
Study: NCT03967353

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: New management mode intervention
Description: Patients in routine treatment group use TB assistant APP. Medical staff strengthen health promotion of the patients,including, infection control, doctor-patient communication, etc.
Study: NCT02232906

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: intravenous ferric carboxymaltose
Description: Ferric carboxymaltose (FCM) dose of 1,000 mg iron, followed by a 6-month ESA/FCM maintenance regimen (target: Hemoglobin 120 g/L, transferrin saturation \>20%)
Study: NCT03458104

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cone Beam Computed Tomography
Description: Cone Beam CT of the larynx

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cone Beam Computed Tomography
Description: Cone Beam CT of the larynx

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Acoustic/Auerodynamic testing
Description: Records and displays real-time sound pressure level intensity, intraoral pressure, airflow rate, and fundamental frequency

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Acoustic/Auerodynamic testing
Description: Records and displays real-time sound pressure level intensity, intraoral pressure, airflow rate, and fundamental frequency

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Laryngovideostroboscopy
Description: Visualization of vocal cords in slow motion. It uses a stroboscopic lamp, which generates regular flashes of light. A flexible tube is inserted in the back of the mouth or through the nose and into the throat. Video pictures are then recorded while patients are making sound.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Laryngovideostroboscopy
Description: Visualization of vocal cords in slow motion. It uses a stroboscopic lamp, which generates regular flashes of light. A flexible tube is inserted in the back of the mouth or through the nose and into the throat. Video pictures are then recorded while patients are making sound.
Study: NCT02042274

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fish oil supplement
Description: Participants are instructed to consume fish oil supplements on a daily basis for a 3-month period.
Study: NCT03045796

Intervention type: DEVICE
Intervention: Oxygen Saturation measured by WristOx
Description: Patients will be hooked up to finger cuffs as well as ECGs to monitor oxygen saturations in different part of the body.
Study: NCT02856672

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Supreme Laryngeal Mask Airway
Description: Supreme Laryngeal Mask Airway

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Supreme Laryngeal Mask Airway
Description: Supreme Laryngeal Mask Airway

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Laryngeal Tube Suction Disposable
Description: Laryngeal Tube Suction Disposable

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Laryngeal Tube Suction Disposable
Description: Laryngeal Tube Suction Disposable
Study: NCT03108443

Intervention type: DIAGNOSTIC_TEST
Intervention: Optical Coherence tomography angiography
Description: All subjects will have OCT angiography imaging performed

Intervention type: DIAGNOSTIC_TEST
Intervention: Optical Coherence tomography angiography
Description: All subjects will have OCT angiography imaging performed
Study: NCT02865447

Intervention type: DEVICE
Intervention: total hip arthroplasty implant
Description: PROFEMUR PRESERVE total hip arthroplasty femoral stem
Study: NCT02670811

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fermented milk
Description: 150 mL daily of fermented milk with Lactococcus lactis NRRL-B50571

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Acidified milk
Description: 150 mL daily of artificially acidified milk
Study: NCT03088735

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Blastocyst-stage embryo transfer strategy
Description: Intra-uterine transfer of blastocist if in cleavage embryo stage the oocyte recipient has a mínimum of 3 availables embryos with at least one of good quality to transfer and also the inta-uterine transfer of cleavage embryo (day 3) when the recipient doesn't have the previous criteria.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cleavage-stage embryo transfer strategy
Description: Inta-uterine transferring of cleavage embryo transfer (day 3 of develpment) in oocyte recipients
Study: NCT00644800

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ziprasidone
Description: Intramuscular ziprasidone 10 or 20 mg at the investigator's discretion for 1 to 3 days followed by oral ziprasidone capsules 40 to 80 mg twice daily at the investigator's discretion to complete 7 days of treatment
Study: NCT00479427

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GW842166
Description: 100 mg once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: once daily
Study: NCT05350397

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: How Important Is Acupress Applyıng In Atrıal Fıbrılatıon Treatment?
Description: The acupressure wristband was correctly attached to the Experimental Group and acupressure was applied. The placebo group was fitted with an inverted and loose acupressure wristband. No intervention was applied to the control group.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: How Important Is Acupress Applyıng In Atrıal Fıbrılatıon Treatment?
Description: The acupressure wristband was correctly attached to the Experimental Group and acupressure was applied. The placebo group was fitted with an inverted and loose acupressure wristband. No intervention was applied to the control group.
Study: NCT05022732

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Polyglucosamine L112
Description: 750 mg of chitosan for tablet formulated with ascorbic acid and tartaric acids in the relative proportions of 91-6-3% with the addition of formulating excipients

Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: excipients and gum arabic
Study: NCT02694692

Intervention type: PROCEDURE
Intervention: Vaccinations at 2, 6, 12 and 18 month
Description: Participants will be invited back to IWK Health Centre at time points that correspond to their 2, 6, 12 and 18 month vaccinations and will receive their vaccinations according to Nova Scotia schedule.

Intervention type: BEHAVIORAL
Intervention: Neurodevelopment assessment at 18 corrected age
Description: During the 18 month follow-up visit, the infants will also undergo neurodevelopmental assessment. Trained medical assessors also blind to original study group assignment will examine the child using the BSID-III Cognitive and Motor Sections. Participants will also be contacted at the infants 18 month corrected postnatal age for the BSIDIII. Parents will be asked to complete the Early Childhood Behaviour Questionnaire and the Brief Infant Toddler Social Emotional Assessment.
Study: NCT01747395

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise training
Description: The heart failure patients are subjected to differents protocols of physical training

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise training
Description: The heart failure patients are subjected to differents protocols of physical training

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise training
Description: The heart failure patients are subjected to differents protocols of physical training
Study: NCT04669444

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ventilator
Description: The patient starts at a ventilator driving pressure of 10-15 cm of H2O as per guidelines for patients on ECMO with ARDS. The driving pressure is then decreased as tolerated for two hours to evaluate the effects on pulmonary, cardiac, and inflammatory biomarkers.
Study: NCT00510822

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cimicoxib
Description: 50 mg per tablet, bid (total daily dose 100 mg)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: tablet
Study: NCT01691222

Intervention type: DEVICE
Group type: OTHER
Intervention: Double lumen endotracheal tube tracheostomy
Description: Percutaneous tracheostomy in this study will be performed with the use of a dedicated double-lumen endotracheal tube.~The dedicated double-lumen endotracheal tube (Deas S.R.L, Italy) has an upper and a lower lumen. The upper one will be occupied by flexible fiberoptic bronchoscope while the lower one is exclusively dedicated to patient ventilation during the procedure. The lower lumen has a a semi-elliptical cross section. This tube will be placed in the patient airway with a direct laryngoscopy. After this intubation, a percutaneous dilatational tracheostomy will be performed with the standard techniques recognised in the literature.
Study: NCT04052152

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anlotinib and Sintilimab injection
Description: Patients will be treated with Anlotinib and Sintilimab injection
Study: NCT02505919

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AQUABEAM System
Description: The AQUABEAM system, a personalized image-guided tissue removal system, utilizes proprietary heat-free high-velocity waterjet technology to resect and remove prostate tissue.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transurethral Resection of the Prostate (TURP)
Description: Transurethral resection of the prostate (TURP) is a type of prostate surgery done to relieve moderate to severe urinary symptoms caused by an enlarged prostate, a condition known as benign prostatic hyperplasia (BPH)
Study: NCT02117297

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemtuzumab Ozogamicin
Description: Gemtuzumab, 9.0 mg/m2, will be given IV over 2 hours two times post allogeneic transplantation.
Study: NCT02297594

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK0529
Description: AK0529 capsule for oral administration

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sugar placebo capsule for oral administration
Study: NCT04350762

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Protein shake + Fish Oil
Description: 2 shakes of protein as well as 1 fish oil daily.
Study: NCT00684008

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CYT107 - Recombinant glycosylated human interleukin 7.
Description: Patients will be treated with CYT107 60 to 210 days post transplantation, in 3 successive cohorts of 3 patients. Escalating doses of CYT107 will be given to successive cohorts. Patients will receive 1 dose of CYT107 by the subcutaneous route, once a week for 3 weeks. Dose level 1: 10 mcg/kg/dose for 3 doses; Dose level II: 20 mcg/kg/dose for 3 doses; Dose level III: 30 mcg/kg/dose for 3 doses. Only 1 treatment course for this initial study.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rhIL-7 (CYT107)
Description: 10, 20, or 30 mcg/kg once a week for 3 consecutive weeks via the subcutaneous route.
Study: NCT02763280

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ginseng extract 1g
Description: Ginseng extract 1g, parallel design

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ginseng extract 3g
Description: Ginseng extract 3g, parallel design

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo, parallel design
Study: NCT00565084

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ibuprofen
Description: Patients will receive 800 mg ibuprofen in one of the three treatment periods.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients will receive placebo to ibuprofen in two of the three treatment periods.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients will receive placebo to ibuprofen in two of the three treatment periods.
Study: NCT01398306

Intervention type: OTHER
Intervention: Blood sampling by vena punction.
Description: We obtain 10mL blood of the patients. The blood is obtained twice: once with angiogenesis inhibitors or mTOR inhibitors, and once without.

Intervention type: OTHER
Intervention: Blood sampling by vena punction.
Description: We obtain 10mL blood of the patients. The blood is obtained twice: once with angiogenesis inhibitors or mTOR inhibitors, and once without.
Study: NCT06343480

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Labour Induction
Description: the use of misoprostol sublingual for labour induction compared with oxytocin titration in parturients with prelabour membrane rupture at term.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Labour Induction
Description: the use of misoprostol sublingual for labour induction compared with oxytocin titration in parturients with prelabour membrane rupture at term.
Study: NCT00604487

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ARD (Atad Ripener Device)
Description: Atad double balloon ripener device

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: AID (Atad double balloon Instillation Device)
Description: Double balloon instillation device and continuous extra-amniotic instillation of NS 50 Ml/hour

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: folly catheter
Description: folly catheter (40 ml NS in the balloon) and continuous extra-amniotic instillation of NS 50 Ml/hour
Study: NCT05178004

Intervention type: OTHER
Intervention: Faecal and Urine sample collection
Description: This is an observational study.

Intervention type: OTHER
Intervention: Faecal and Urine sample collection
Description: This is an observational study.

Intervention type: OTHER
Intervention: Faecal and Urine sample collection
Description: This is an observational study.

Intervention type: OTHER
Intervention: Faecal and Urine sample collection
Description: This is an observational study.
Study: NCT04512157

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Promoting Alternative Thinking Strategies (PATHS), Preschool Edition
Description: PATHS® is a universal teacher implemented, and school-based intervention that aims to give preschool children a strategically timed boost in social emotional competence. Specifically, PATHS® encourages the use of interactive techniques to bolster children's ability to self-regulate, increase their adeptness at social cognitive problem solving, as well as to gain insight into their emotions and emotions of others.
Study: NCT01685502

Intervention type: DRUG
Intervention: Glucobay ODT (Acarbose, BAYG5421)
Description: Patients treated with Glucobay OD under practical manner
Study: NCT02584010

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Silicon-based aerosol
Description: Apply twice a day over the postoperative scar

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Silicon-based gel
Description: Apply twice a day over the postoperative scar